Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jun 18:4:1-8.
doi: 10.1016/j.conctc.2016.06.002. eCollection 2016 Dec 15.

Critical appraisal of the clinical utility of sublingual immunotherapy in allergy

S Aissa  1 , R Ben Jazia  1 , J Ayachi  2 , C Ben Salem  3 , A Hayouni  1 , A Abdelghani  1 , H Ben Saad  4 , M Boussarsar  2
Affiliations
Review

Critical appraisal of the clinical utility of sublingual immunotherapy in allergy

S Aissa et al. Contemp Clin Trials Commun. .

Abstract

Since it was introduced by Noon in 1911, allergen-specific immunotherapy or desensitization has been widely prescribed in the management of allergic diseases. Aimed at the etiology, it represents the only effective treatment for allergy. The basic mechanisms of immunotherapy are becoming better understood and allow us to improve this technique in the future. The sublingual immunotherapy as an alternative to subcutaneous route has been widely studied. Several clinical trials confirmed that sublingual immunotherapy is efficient in reducing allergic respiratory symptoms. The sublingual immunotherapy reduces the risk of developing serious side effects due to desensitization. We performed a literature review in order to remind the mechanisms of action and to demonstrate efficacy and tolerability of the sublingual immunotherapy in the treatment of allergic rhinoconjunctivitis and asthma and its impact on the quality of life.

Keywords: Allergen specific immunotherapy; Allergy; Asthma; Rhinoconjunctivitis; Sublingual immunotherapy.

PubMed Disclaimer

References

    1. Bourdin A., Doble A., Godard P. The asthma insights and reality in the Maghreb (AIRMAG) study: perspectives and lessons. Respir. Med. 2009 Dec;103(Suppl 2):S38–S48. - PubMed
    1. Noon L. Prophylactic inoculation against hay fever. Lancet. 1911;1:1572–1573.
    1. Cox L., Nelson H., Lockey R. Allergen immunotherapy: a practice parameter third update. J. Allergy Clin. Immunol. 2011;127:S1–S55. - PubMed
    1. Bahceciler N.N., Arikan C., Taylor A. Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites. Int. Arch. Allergy Immunol. 2005;136:287–294. - PubMed
    1. Wachholz P.A., Durham S.R. Induction of ’blocking’ IgG antibodies during immunotherapy. Clin. Exp. Allergy. 2003;33:1171–1174. - PubMed

LinkOut - more resources